ACA
BIIB icon

Avoro Capital Advisors’s Biogen BIIB Stock Holding History

Avoro Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-84,000
Closed -$23.8M – 43
2021
Q3 		$23.8M Buy
+84,000
New +$27.5M 0.37% 35
2015
Q3 		– Sell
-4,500
Closed -$1.82M – 36
2015
Q2 		$1.82M Buy
+4,500
New +$1.81M 0.5% 28

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Avoro Capital Advisors's BIIB Position: Q4 2021 in Review

Avoro Capital Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 84,000 shares — an estimated $23.8M sold.

Avoro Capital Advisors first reported a position in BIIB in Q2 2015 and held it in 2 quarters. The position peaked at $23.8M in Q3 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Avoro Capital Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Avoro Capital Advisors sold 84,000 Biogen shares in Q4 2021, an estimated $23.8M.
  • Avoro Capital Advisors first reported a position in Biogen in Q2 2015 and held it in 2 quarters.
  • Avoro Capital Advisors's Biogen position peaked at $23.8M in Q3 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Avoro Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.